US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1  2  3  4    6    8  9  10  
Metastatic Colorectal Cancer - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Metastatic Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Neuroblastoma - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... Neuroblastoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Varicella Zoster (HHV-3) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM
8/20/2014 | published by: GBI Research
... research, Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM, which provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within ...  |  read more...
USD 4,995
PCSK9 and Other Novel Hypercholesterolemia Drugs Market, 2014 - 2024
9/5/2014 | published by: Roots Analysis
... available options, statins have been ubiquitously prescribed over the last 25 years. Researchers have concluded that reduction of plasma LDL cholesterol (LDLC) is the cornerstone of assessing heart risk. Irrespective of baseline cholesterol concentration, each ...  |  read more...
USD 1,899
Small-Cell Lung Cancer - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Small-Cell Lung Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014
8/20/2014 | published by: GlobalData
... information and data relating to the clinical trials on Chagas Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Sickle Cell Disease Global Clinical Trials Review, H2, 2014
8/20/2014 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Sickle Cell Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
USD 2,500
Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2014
8/20/2014 | published by: GlobalData
... information and data relating to the clinical trials on Coronary Arteriosclerosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Diabetic Neuropathy - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... therapeutic development for Diabetic Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Typhoid Fever - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... therapeutic development for Typhoid Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Perennial Allergic Rhinitis - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... information on the therapeutic development for Perennial Allergic Rhinitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Severe Psoriasis - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... therapeutic development for Severe Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Amyloidosis - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... Amyloidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Female Sexual Dysfunction - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... information on the therapeutic development for Female Sexual Dysfunction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Fecal Incontinence - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... therapeutic development for Fecal Incontinence, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Narcolepsy - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... Narcolepsy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Leukemia Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors leukemia technology. These deals tend to be multicomponent, starting with collaborative ...  |  read more...
USD 995
Peripheral Arterial Disease Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... in peripheral arterial disease partnering deals Top peripheral arterial disease deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Peripheral Arterial Disease Partnering 2009-2014 provides understanding and access to ...  |  read more...
USD 695
Thrombus 2009-2014
8/1/2014 | published by: Current Partnering
... value Deals listed by company A-Z, industry sector, stage of development, technology type Thrombus Partnering 2009-2014 provides understanding and access to the thrombus partnering deals and agreements entered into by the worlds leading healthcare companies. ...  |  read more...
USD 695
Parkinson's Disease Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... analysis of Parkinson’s disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors Parkinson’s disease technology. These deals tend ...  |  read more...
USD 995
Psoriasis Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... by value •Deals listed by company A-Z, industry sector, stage of development, technology type Psoriasis Partnering 2009-2014 provides understanding and access to the psoriasis partnering deals and agreements entered into by the worlds leading healthcare ...  |  read more...
USD 695
Sun Damage Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... deals •Top sun damage deals by value •Deals listed by company A-Z, industry sector, stage of development, technology type Sun Damage Partnering 2009-2014 provides understanding and access to the sun damage partnering deals and agreements ...  |  read more...
USD 995
Huntington's Disease Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... deals •Top huntington's disease deals by value •Deals listed by company A-Z, industry sector, stage of development, technology type Huntington's Disease Partnering 2009-2014 provides understanding and access to the huntington's disease partnering deals and agreements ...  |  read more...
USD 695
1  2  3  4    6    8  9  10